GSK369796
GSK369796 is an affordable and effective antimalarial and inhibits hERG potassium ion channel repolarization with an IC50 of 7.5 μM.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 459133-38-1
- 分子式: C20H22ClN3O
- 分子量:355.86
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Parasite アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BHK-21 | CC50 |
98.01 μM
Compound: 42; GSK369796
|
Cytotoxicity against BHK21 cells after 24 to 48 hrs by CCK8 assay
Cytotoxicity against BHK21 cells after 24 to 48 hrs by CCK8 assay
|
[PMID: 31549836] |
| Vero | EC50 |
2.57 μM
Compound: 42; GSK369796
|
Antiviral activity against Zika virus MR766 infected in African green monkey Vero cells by plaque assay
Antiviral activity against Zika virus MR766 infected in African green monkey Vero cells by plaque assay
|
[PMID: 31549836] |
| Vero C1008 | EC50 |
1.2 μM
Compound: N-tert-Butylisoquine
|
Determination of antiviral efficacy in high-content imaging assay in Vero E6 cells infected with SARS-CoV-2 (USA-WA1/2020 isolate) at MOI 0.75 after 24 hrs
Determination of antiviral efficacy in high-content imaging assay in Vero E6 cells infected with SARS-CoV-2 (USA-WA1/2020 isolate) at MOI 0.75 after 24 hrs
|
10.1101/2020.04.16.044016 |
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
化学情報
-
CAS 番号 459133-38-1
-
分子量 355.86
-
分子式 C20H22ClN3O
-
SMILES
OC1=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=CC=C1CNC(C)(C)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)